Press. Senstive (526773)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Reported ROCE of 22.67% is positive, suggesting some operating capital efficiency if the underlying capital base is real.
• Latest quarter net loss is effectively ₹0 crore, so there is no immediate large cash burn.
• Small market cap of ₹99 crore gives a low base if a genuine operational restart happens.
• Stock is at the top of its 52-week range, showing current market interest and liquidity.

Concerns

• Sales growth of -100% means current revenue is zero; core operations appear to have stopped.
• P/E is 0.00, dividend yield is 0%, and ROE is negative at -1.57%, making earnings-based valuation impossible.
• Piotroski F-Score of 3/9 signals weak overall financial health.
• Book value, debt/equity, and promoter holding are undisclosed, leaving no margin of safety to calculate.

AI Analysis

Let's begin with the obvious: a company reporting ₹0 crore sales and essentially ₹0 crore net profit is not an operating business in the traditional sense. The P/E of 0.00 is meaningless; price-to-book is blank; book value is blank. Sales growth of -100% and profit growth of -100.81% tell me the enterprise has collapsed, not grown. Benjamin Graham always said to look at the figures, not the story. The figures here are a story of cessation. ROE is -1.57%, and the Piotroski F-Score is a weak 3/9, indicating poor financial health. The one supposedly bright number, ROCE of 22.67%, looks contradictory when sales are zero. It may be an artifact of a small or negative capital base, or non-operating income, but I cannot take it at face value without a balance sheet. Market cap is ₹99 crore at ₹6.48, near the top of a 52-week range that started at ₹0.96. So Mr. Market has already re-rated the stock upward almost six-fold, while the business fundamentals have gone in the opposite direction. This is a speculative momentum move, not value investing. As Warren Buffett says, 'You pay a very high price for a cheery consensus.' I need hard evidence: audited book value, debt/equity, promoter holding, and a concrete plan to restart sales. Without those, this is strictly a pass. I'd rather miss a speculative rebound than lose capital on a shell company with no earnings visibility.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer